Follow
Jonathan Karnon
Title
Cited by
Cited by
Year
Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ...
Value in Health 15 (6), 835-842, 2012
7222012
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6
AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ...
Medical decision making 32 (5), 722-732, 2012
7112012
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–4
J Karnon, J Stahl, A Brennan, JJ Caro, J Mar, J Möller
Medical decision making 32 (5), 701-711, 2012
5562012
A systematic review of economic analyses of telehealth services using real time video communication
VA Wade, J Karnon, AG Elshaug, JE Hiller
BMC health services research 10, 1-13, 2010
4002010
Trends in healthcare incident reporting and relationship to safety and quality data in acute hospitals: results from the National Reporting and Learning System
A Hutchinson, TA Young, KL Cooper, A McIntosh, JD Karnon, S Scobie, ...
BMJ Quality & Safety 18 (1), 5-10, 2009
2622009
Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.
J Karnon, J Peters, J Platt, J Chilcott, E McGoogan, N Brewer
Health technology assessment (Winchester, England) 8 (20), iii, 1-78, 2004
2482004
The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic …
J Carlton, J Karnon, C Czoski-Murray, KJ Smith, J Marr
Health technology assessment (Winchester, England) 12 (25), iii, xi-194, 2008
2112008
Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation
J Karnon
Health economics 12 (10), 837-848, 2003
2112003
Process mining for clinical processes: a comparative analysis of four Australian hospitals
A Partington, M Wynn, S Suriadi, C Ouyang, J Karnon
ACM Transactions on Management Information Systems (TMIS) 5 (4), 1-18, 2015
2042015
A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the rapid assessment of possible acute coronary syndrome in the emergency department …
DP Chew, K Lambrakis, A Blyth, A Seshadri, MJR Edmonds, T Briffa, ...
Circulation 140 (19), 1543-1556, 2019
1982019
Estimating the reference incremental cost-effectiveness ratio for the Australian health system
LC Edney, H Haji Ali Afzali, TC Cheng, J Karnon
Pharmacoeconomics 36, 239-252, 2018
1942018
Model‐based cost‐effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation)
J Karnon, F Campbell, C Czoski‐Murray
Journal of evaluation in clinical practice 15 (2), 299-306, 2009
1872009
Calibrating models in economic evaluation: a seven-step approach
T Vanni, J Karnon, J Madan, RG White, WJ Edmunds, AM Foss, R Legood
Pharmacoeconomics 29, 35-49, 2011
1802011
Option appraisal of population-based colorectal cancer screening programmes in England
P Tappenden, J Chilcott, S Eggington, H Sakai, J Karnon, J Patnick
Gut 56 (5), 677-684, 2007
1662007
A review and critique of modelling in prioritising and designing screening programmes
J Karnon, E Goyder, P Tappenden, S McPhie, I Towers, J Brazier, ...
HEALTH TECHNOLOGY ASSESSMENT-SOUTHAMPTON- 11 (52), 2007
1622007
Identifying existing health care services that do not provide value for money
AG Elshaug, JR Moss, P Littlejohns, J Karnon, TL Merlin, JE Hiller
Medical Journal of Australia 190 (5), 269-273, 2009
1542009
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report
B John, A Roberta, A Ismail, B Jan, CS Hélène, C Bruce, C Luciane, ...
Value in Health 22 (3), 267-275, 2019
1412019
A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs)
S Ishaque, J Karnon, G Chen, R Nair, AB Salter
Quality of Life Research 28, 567-592, 2019
1282019
The role of modelling in prioritising and planning clinical trials
J Chilcott, A Brennan, A Booth, J Karnon, P Tappenden
Health Technol Assess 7 (23), 1-125, 2003
1262003
Lifetime treatment costs of β‐thalassaemia major
J Karnon, D Zeuner, J Brown, AE Ades, B Wonke, B Modell
Clinical & Laboratory Haematology 21 (6), 377-385, 1999
1261999
The system can't perform the operation now. Try again later.
Articles 1–20